Malignant neoplasm of peripheral nerves of lower limb, including hip
ICD-10 C47.2 is a billable code used to indicate a diagnosis of malignant neoplasm of peripheral nerves of lower limb, including hip.
C47.2 refers to malignant neoplasms that arise from the peripheral nerves located in the lower limb, including the hip region. These tumors can be classified as soft tissue sarcomas, which are cancers that originate in the connective tissues of the body. Peripheral nerve sheath tumors (PNSTs) are the most common type of malignant neoplasm in this category, often presenting as painful masses that may cause neurological symptoms due to nerve compression. Grading of these tumors is crucial, as it helps determine the aggressiveness of the cancer and guides treatment options. Low-grade tumors tend to grow slowly and have a better prognosis, while high-grade tumors are more aggressive and may metastasize. Multidisciplinary management is essential for optimal outcomes, involving surgical resection, radiation therapy, and chemotherapy as needed. Collaboration among oncologists, surgeons, radiologists, and pathologists is vital to ensure comprehensive care and accurate staging of the disease.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of soft tissue sarcomas, including staging and grading.
Ensure accurate coding of tumor grade and type, as well as any metastasis.
Operative reports, pre-operative assessments, and post-operative follow-ups.
Surgical resection of malignant peripheral nerve tumors.
Document the extent of resection and any complications that may arise.
Used during surgical resection of a malignant peripheral nerve tumor.
Operative report detailing the extent of resection and pathology results.
Ensure coordination between surgical and oncology teams for comprehensive care.
Tumor grading is crucial as it indicates the aggressiveness of the cancer, influencing treatment decisions and prognosis. High-grade tumors are more likely to metastasize and require more aggressive treatment.
